Hydralazine Hydrochloride 23155-0833
Product NDC
23155-0833- Manufacturer
- Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 2, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA040858
Need to source Hydralazine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydralazine Hydrochloride | 25 mg/1 |
Drug Class
Arteriolar Vasodilation [PE]Arteriolar Vasodilator [EPC]
Packaging Options(2)
100 TABLET in 1 BOTTLE (23155-833-01)
1000 TABLET in 1 BOTTLE (23155-833-10)